Chinese regulators have approved a coronavirus vaccine developed by state owned pharmaceutical giant Sinopharm , officials announced Thursday . 
Sinopharm said yesterday its coronavirus vaccine is 79.34 % effective , citing interim analysis of Phase 3 clinical trials . 
Though few details were provided , the company said the vaccine met the standards of the World Health Organization and China 's own regulator , the National Medical Products Administration . 
Read more about the Sinopharm vaccine : 
